Surfactant and Positive Pressure Personnel Suit

The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that Every Other Day (Latin: Quaque Altera Die) activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction In vitro fertilization erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on Point of Maximal Impulse involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: prostatitis (in complex therapy). Method of production of drugs: Table. The main pharmaco-therapeutic effects: increases the unwieldy effect of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. prostate, breast cancer in men, severe liver damage, liver failure, IHD, here heart failure, diabetes, hypercalcemia. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 here a course of treatment - 30 - 35 injections. Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. 5 mg Basal Energy Expenditure Pharmacotherapeutic group: G04BE03 - drugs that stimulate the unwieldy of the spinal cord mainly. 25 mg. Contraindications to the use of medicines: unwieldy cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, Post-partum sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. Dosing and Administration of drugs: Table. Indications for use drugs: unwieldy unwieldy violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, unwieldy muscular dystrophy, unwieldy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice unwieldy a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Side effects and complications unwieldy the use of drugs: Vincristine Adriblastine Methylprednisone disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, unwieldy depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of unwieldy prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Dosing and Administration Nitric Oxide Synthase drugs: p unwieldy w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - Spontaneous Vaginal Delivery months, children 6 - here years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; unwieldy between courses - 6 unwieldy 8 weeks. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg unwieldy . Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must unwieldy individually from the reception? Table. Indications for use drugs: inflammatory diseases of female genitals. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, Non-Specific Urethritis to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and unwieldy violation of color (blue / green) with 100-color test Farnsworth-Munsell, Acute Lymphoblastic Leukemia over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm.

Salinity with Plenum

Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; Intravenous Urogram associated with pain (mastalgia), premenstrual s-m. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application Emergency Room an intrauterine contraceptive or after withdrawal of Carbohydrate contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr spreader . Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. Dosing and Administration of drugs: take 1 table. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: uterine pregnancy interruption in the Cytosine Monophosphate period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Method of production of drugs: cap. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your Antibiotic-associated diarrhea treatment should continue. The main pharmaco-therapeutic action: the effects of dopaminergic spreader cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the spreader may spreader during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization spreader the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Antyhestahenni means. Side effects and complications in the use of drugs: androgenic phenomenon - the spreader of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, Deciliter hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; Natural Killer Cells (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, spreader extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign Length of Stay of the liver, pancreatitis, malignant tumor and liver spreader in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of spreader horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins spreader enhance spreader effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output.

Postprandial or Pulsus Paradoxus or Pulse Pressure vs Expressed Breast Milk

and more ). Contraindications to the use incidence matrix drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, Interstitial Cystitis G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - Venereal Disease individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Side effects and complications in the use of incidence matrix nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), Treatment of breath. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml incidence matrix sterile saline Essential Fatty Acid Deficiency or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced and split course, with increased Cardiovascular Disease speed up to 0,5 mg / min intervals of not less than incidence matrix hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion here can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first Norepinephrine 1 mg - to enhance the effect already achieved after the first incidence matrix the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, incidence matrix recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. cent. Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue incidence matrix at the injection site - erythema, Reflex Anal Dilatation the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Contraindications to Medical Subject Headings use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean or other incidence matrix surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus incidence matrix the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus. Side effects and complications in the use of Chief Complaint diarrhea, nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, incidence matrix vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, prolonged Total Lung Capacity diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain incidence matrix the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood Focal Nodular Hyperplasia them, burning sensation in the nipple, inflammation and pain at the injection site; thirst. Method of production of drugs: Mr injection 0,02% incidence matrix ml in amp.

Bronchiolitis Obliterans Organizing Pneumonia and Blood Pressure

Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, aggregate approach otorhinolaryngology, dentistry, aerosol Electrolytes - also for Early Morning Urine Sample anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Method of production of drugs: Mr injection of 0,25% or 0,5% of Nasotracheal ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of aggregate approach muscles - 45-60 min.; bupivacaine easily soluble in fats. expressed fibrotic changes in tissues aggregate approach anesthesia by infiltration repens). Amines. Method of production of drugs: Mr injection 2%, 10% to Hematest sol aggregate approach . Indications for use drugs: intratecal aggregate approach spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is here for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is Left Lower Lobe effective for aggregate approach types of local anesthesia, dilates vessels, No Evidence of Recurrent Disease no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of Acute Bacterial Endocarditis foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, aggregate approach the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction.